| Net income (loss) | -730.38M |
| Depletion, depreciation and amortization | 246.77M |
| Unit-based compensation expense | 12.65M |
| Unrealized (gain) loss on derivative instruments | |
| Income from equity affiliates, net | -365K |
| Deferred income taxes | -804K |
| Amortization of intangibles | |
| Loss on sale of assets | |
| Other | 3.44M |
| Accounts receivable and other assets | 15.05M |
| Inventory | -437K |
| Net change in related party receivables and payables | 1.38M |
| Accounts payable and other liabilities | 68.6M |
| Net cash provided by operating activities | 184.41M |
| Capital expenditures | |
| Proceeds from sale of assets | 11.88M |
| Property acquisitions | -7.53M |
| Net cash used in investing activities | -55.24M |
| Issuance of common units | 0 |
| Distributions | |
| Proceeds from issuance of long-term debt | 38.26M |
| Repayments of long-term debt | -69M |
| Change in book overdraft | -75K |
| Long-term debt issuance costs | -3K |
| Net cash used in financing activities | -40.23M |
| Decrease in cash | 88.94M |
| Cash beginning of period | 10.46M |
| Cash end of period | 99.4M |